FRA
DGX icon

Front Row Advisors’s Quest Diagnostics DGX Stock Holding History

Front Row Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-135
Closed -$18.5K – 598
2024
Q2 		$18.5K Hold
135
– – 0.01% 449
2024
Q1 		$18K Buy
+135
New +$17.5K 0.01% 442
2023
Q4 		– Sell
-135
Closed -$16.5K – 566
2023
Q3 		$16.5K Hold
135
– – 0.01% 422
2023
Q2 		$19K Hold
135
– – 0.01% 387
2023
Q1 		$19K Hold
135
– – 0.01% 385
2022
Q4 		$21K Hold
135
– – 0.01% 363
2022
Q3 		$17K Hold
135
– – 0.01% 411
2022
Q2 		$18K Hold
135
– – 0.01% 409
2022
Q1 		$18K Hold
135
– – 0.01% 440
2021
Q4 		$23K Hold
135
– – 0.01% 397
2021
Q3 		$20K Hold
135
– – 0.01% 421
2021
Q2 		$20K Hold
135
– – 0.01% 417
2021
Q1 		$17K Hold
135
– – 0.01% 438
2020
Q4 		$16K Hold
135
– – 0.01% 419
2020
Q3 		$17K Hold
135
– – 0.01% 398
2020
Q2 		$15K Hold
135
– – 0.01% 383
2020
Q1 		$15K Sell
135
-39
-22% -$4.04K 0.01% 379
2019
Q4 		$19K Sell
174
-31
-15% -$3.23K 0.01% 336
2019
Q3 		$22K Buy
205
+21
+11% +$2.16K 0.02% 300
2019
Q2 		$19K Buy
184
+10
+6% +$961 0.01% 329
2019
Q1 		$16K Buy
174
+39
+29% +$3.38K 0.01% 356
2018
Q4 		$11K Hold
135
– – 0.01% 385
2018
Q3 		$12K Hold
135
– – 0.01% 392
2018
Q2 		$14K Sell
135
-29
-18% -$3.02K 0.01% 394
2018
Q1 		$16K Hold
164
– – 0.01% 353
2017
Q4 		$16K Buy
+164
New +$15.5K 0.01% 366

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Front Row Advisors's DGX Position: Q3 2024 in Review

Front Row Advisors sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 135 shares — an estimated $18.5K sold.

Front Row Advisors first reported a position in DGX in Q4 2017 and held it in 26 quarters. The position peaked at $23K in Q4 2021. 847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

  • Front Row Advisors reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 135 Quest Diagnostics shares in Q3 2024, an estimated $18.5K.
  • Front Row Advisors first reported a position in Quest Diagnostics in Q4 2017 and held it in 26 quarters.
  • Front Row Advisors's Quest Diagnostics position peaked at $23K in Q4 2021.
  • 847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.